OncLive - Bringing the Oncology Community Together

An underlying autoimmune condition may have played a role in making a 13-year-old patient refractory to treatment for immune thrombocytopenia. Read More >>

Ponatinib Shows Promise in Pediatric/Adolescent ALL Patients

Expert Weighs Treatment Methods in Hodgkin Lymphoma

Novel Immunotherapy Shows Early Efficacy in Uveal Melanoma

Emerging Trastuzumab Biosimilar May Promote Competition

A Whirlwind of Change in Lung Cancer

View More Stories >>

View Conference Coverage

2018 ASCO Annual Meeting

2018 ASPHO Conference

2018 State of the Science Summit on Genitourinary Cancers

2018 State of the Science Summit on Gastrointestinal Cancers

2018 State of the Science Summit on Hematologic Malignancies

Dr. McGregor on New Combinations With Immunotherapy in RCC

Dr. Pegram Discusses the Use of Neratinib in HER2+ Breast Cancer

Dr. Trabulsi Discusses Postoperative Radiation in Prostate Cancer

Dr. Newman on Advances in Axillary Surgery in Breast Cancer

Dr. Simon on Genomic Assays for Patients With Breast Cancer

Dr. Gold on the Future of Osimertinib in Lung Cancer

Dr. Ramanathan on Emerging Therapeutic Targets in Patients With Pancreatic Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Managing Advanced Prostate Cancer in the Future

Hereditary Prostate Cancer Testing in Practice

Improvements in Detecting and Treating Metastatic CRPC

Renal Cell Carcinoma: An Evolving Treatment Landscape

OncLive houses thousands of videos that provide updates and information.
See more Videos

First-Line Therapy in Advanced HCC

$Evaluating Pharmacologic Agents in Relapsed/Refractory CLL$

Evaluating Pharmacologic Agents in Relapsed/Refractory CLL

When to Move to Systemic Therapy in HCC

CLL: Post-Ibrutinib or Chemoimmunotherapy Approaches

HCC: Role of Radiotherapy and Measuring Response

Future Treatment Strategies in Non-Small Cell Lung Cancer

$Approaching Therapy for Relapsed/Refractory CLL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

Relapsed/Refractory ALL: Evaluating Novel Agents

$Relapsed/Refractory ALL: Evaluating Novel Agents$
A unique opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval of Biosimilar, Proposed Change in US Drug Prices, and 2018 ASCO Presscast